West Pharmaceutical Services WST Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Proprietary Products | $722.6M+16.6% | $694.3M+23.3% | $661.8M+7.8% | $647.5M+7.7% | $619.8M+10.7% | |
| West Vantage | $149.7M+2.0% | $150.6M+11.6% | —— | —— | $146.7M— | |
| Concentration risk, percentage by Product | ||||||
| High-Value Product ("HVP") Components | 49%+2.0pp | 48%+3.0pp | —— | 48%+3.0pp | 47%+1.0pp | |
| High-Value Product ("HVP") Delivery Devices | 15%+2.0pp | 15%+1.0pp | —— | —— | 13%— | |
| Standard Packaging | 19%-2.0pp | 19%-3.0pp | 8%-2.0pp | 12%-4.0pp | 21%+10.0pp | |
| West Vantage | 17%-2.0pp | 18%-1.0pp | —— | —— | 19%— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does West Pharmaceutical Services break its business down?
- West Pharmaceutical Services (WST) reports net sales by business across 2 parts — Proprietary Products and West Vantage. Each is extracted from the segment footnotes and tracked over time.
- Where does West Pharmaceutical Services's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in West Pharmaceutical Services's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
